Imperial and Bayer to use AI for heart conditions

21st December 2018 Uncategorised 0

Researchers at Imperial and Bayer Pharmaceuticals are partnering up to explore how artificial intelligence (AI) can be used to accelerate the discovery of new drugs for heart conditions.

More: Imperial and Bayer to use AI for heart conditions
Source: News